The BH3 mimetic, ABT-737, is effective against Bcl-2 overexpressing lymphoid tumors.
- Author(s)
- Mason, KD; Vandenberg, CJ; van Delft, MF; Wei, AH; Cory, S; Clare, SL; Roberts, AW; Huang, DCS;
- Details
- Publication Year 2006-11-16,Volume 108,Issue #11,Page 248A-248A
- Journal Title
- BLOOD
- Publication Type
- Journal Article
- Publisher
- AMER SOC HEMATOLOGY
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2006-11-16 12:00:00